Literature DB >> 16724669

Persistent cell proliferation of terminal end buds precedes radiation-induced rat mammary carcinogenesis.

Tatsuhiko Imaoka1, Mayumi Nishimura, Yukiko Nishimura, Shizuko Kakinuma, Yoshiya Shimada.   

Abstract

BACKGROUND: The rat model of radiation-induced carcinogenesis is widely used to estimate breast cancer risk, but it is unknown whether mammary terminal end buds (TEBs), the hypothesized target of chemical carcinogens, are also targets of radiation-induced carcinogenesis.
MATERIALS AND METHODS: Female Sprague-Dawley rats were irradiated with X-rays (2 Gy). The morphology, bromodeoxyuridine (BrdU)-labelling index and pyknotic index of mammary ductal termini were investigated from 6 hours to 8 weeks post-irradiation.
RESULTS: The irradiated rats showed a significantly smaller decrease in TEB numbers than the controls 4-8 weeks after irradiation. The BrdU-labelling and pyknotic indices initially decreased and increased, respectively, recovered to control levels by 3 days post-irradiation, and remained significantly higher until 8 weeks and 4 weeks post-irradiation, respectively. One case of ductal hyperplasia was observed at 8 weeks.
CONCLUSION: Irradiation resulted in a persistent proliferation of TEBs, which may be associated with neoplastic transformation via a temporal differentiation arrest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724669

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  2 in total

Review 1.  Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters.

Authors:  Leena Hilakivi-Clarke
Journal:  Breast Cancer Res       Date:  2014       Impact factor: 6.466

Review 2.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Authors:  Jessica S Helm; Ruthann A Rudel
Journal:  Arch Toxicol       Date:  2020-05-13       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.